John Hussman's KNSA Position Overview
John Hussman (via Hussman Strategic Advisors, Inc.) currently holds 21,000 shares of Kiniksa Pharmaceuticals International, plc (KNSA) worth $1.01 M, representing 0.22% of the portfolio. First purchased in 2024-Q1, this short-term holding has been held for 5 quarters.
Based on 13F filings, John Hussman has maintained this position in KNSA for several quarters, showing initial confidence in the investment. Largest addition occurred in Q1 2026, adding 21,000 shares. Largest reduction occurred in Q4 2024, reducing 84,000 shares.
Analysis based on 13F filings available since 2013 Q2
John Hussman's Kiniksa Pharmaceuticals International plc (KNSA) Holding Value Over Time
Track share changes against reported price movement
Quarterly Kiniksa Pharmaceuticals International plc (KNSA) Trades by John Hussman
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +21,000 | New Buy | 21,000 | $48.15 |
| Q4 2024 | -84,000 | Sold Out | 0 | $0.00 |
| Q3 2024 | -63,000 | Reduce 42.86% | 84,000 | $24.99 |
| Q2 2024 | -10,500 | Reduce 6.67% | 147,000 | $18.67 |
| Q1 2024 | +157,500 | New Buy | 157,500 | $19.73 |
John Hussman's Kiniksa Pharmaceuticals International plc Investment FAQs
John Hussman first purchased Kiniksa Pharmaceuticals International, plc (KNSA) in Q1 2024, acquiring 157,500 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
John Hussman has held Kiniksa Pharmaceuticals International, plc (KNSA) for 5 quarters since Q1 2024.
John Hussman's largest addition to Kiniksa Pharmaceuticals International, plc (KNSA) was in Q1 2024, adding 157,500 shares worth $3.11 M.
According to the latest 13F filing for Q1 2026, John Hussman's firm, Hussman Strategic Advisors, Inc., owns 21,000 shares of Kiniksa Pharmaceuticals International, plc (KNSA), valued at approximately $1.01 M.
As of the Q1 2026 filing, Kiniksa Pharmaceuticals International, plc (KNSA) represents approximately 0.22% of John Hussman's publicly disclosed stock portfolio, making it one of their key holdings.
John Hussman's peak holding in Kiniksa Pharmaceuticals International, plc (KNSA) was 157,500 shares, as reported at the end of Q1 2024.